CompletedNot Applicable

Feasibility of a Remotely-Delivered Yoga Intervention on Cognitive Function in Breast Cancer Survivors

Canada18 participantsStarted 2021-12-13

Plain-language summary

The purpose of this pilot study is to assess the feasibility of a remotely-delivered yoga intervention for breast cancer survivors.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ≥18 years of age * primary diagnosis of Stage I-IIIa breast cancer * completed primary treatment(s) * proficient in written and spoken English * access to the Internet and a computer with videoconferencing capabilities Exclusion Criteria: * colour-blind since the objective cognitive tests require participants to distinguish between colours * regular yoga practice defined as ≥2 times/week * major cognitive disorder(s) or impairment(s) (score ≤21 on the Telephone Interview of Cognitive Status)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Enrolment rate

Timeframe: From beginning to end of recruitment period, up to 6 months.

Adherence rate

Timeframe: From beginning to end of intervention period, up to 6 months.

Attrition rate

Timeframe: From beginning to end of intervention period, up to 6 months.

Adverse events

Timeframe: From beginning to end of intervention period, up to 6 months.

Burden and satisfaction

Timeframe: 8 weeks post-baseline

Trial details

NCT IDNCT05180656

SponsorUniversity of Toronto

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-27

View on ClinicalTrials.gov More Breast Cancer trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Enrolment rate

Timeframe: From beginning to end of recruitment period, up to 6 months.

Adherence rate

Timeframe: From beginning to end of intervention period, up to 6 months.

Attrition rate

Timeframe: From beginning to end of intervention period, up to 6 months.

Adverse events

Timeframe: From beginning to end of intervention period, up to 6 months.

Burden and satisfaction

Timeframe: 8 weeks post-baseline